## FCX: Freeport-McMoRan, Inc. - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.9% in upper entry zone (3.0-6.0%), top 9% cross-sectional ranking. Short-term MRS_5 (3.0%) confirms momentum alignment. Strong momentum (+4.0% 5-day acceleration). Outperforming sector by 3.0%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($44.42)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 1, Bearish: 9)

**1. Class Action Filed Against Freeport-McMoRan Inc. (FCX) -**
- Source: GlobeNewswire | 20251215T210756 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has filed a class action lawsuit against Freeport-McMoRan Inc. (FCX) on behalf of investors who suffered losses due to alleged securities fraud between February 15, 2022, and September 24, 2025. The lawsuit claims that Freeport-McMoRan did not adequately ensure safety at its Grasberg Block Cave mine, leading to undisclosed regulatory, litigation, and reputational risks. Investors have until January 12, 2026, to request to be appointed as lead plaintiff.

**2. Robbins LLP Reminds Freeport-McMoran Inc. Stockholders of the January 12, 2026 Lead Plaintiff Deadline â€“ Contact us today for information about the FCX class action**
- Source: Business Wire | 20251215T195633 | Bearish | Relevance: 100%
- Robbins LLP is reminding stockholders of Freeport-McMoran Inc. (NYSE: FCX) about the January 12, 2026, lead plaintiff deadline for a class action lawsuit. The lawsuit alleges that Freeport-McMoran misled investors regarding safety at its Grasberg Block Cave mine in Indonesia, leading to worker fatalities and a subsequent decline in stock value. Shareholders who purchased FCX stock between February 15, 2022, and September 24, 2025, may be eligible to participate.

**3. Lost Money on Freeport-McMoRan Inc. (FCX)? Join Class Action Before January 12, 2026 - Contact Levi & Korsinsky**
- Source: KTLA | 20251215T180815 | Bearish | Relevance: 100%
- Levi & Korsinsky LLP has filed a class action securities lawsuit against Freeport-McMoRan Inc. (FCX) on behalf of shareholders who experienced losses due to alleged securities fraud between February 15, 2022, and September 24, 2025. The lawsuit claims Freeport failed to ensure adequate safety at its Grasberg Block Cave mine in Indonesia, leading to heightened regulatory, litigation, and reputational risks. Affected investors are encouraged to contact Levi & Korsinsky before January 12, 2026, to learn about their rights to seek recovery.

**4. FCX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Freeport-McMoRan Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit**
- Source: FOX40 News | 20251215T170810 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) on behalf of investors who purchased securities between February 15, 2022, and September 24, 2025. The lawsuit alleges that Freeport-McMoRan failed to ensure adequate safety at its Grasberg Block Cave mine, leading to undisclosed risks and investor damages. Investors with substantial losses have until January 12, 2026, to request to be appointed as lead plaintiff.

**5. FCX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC**
- Source: GlobeNewswire | 20251215T170758 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman LLC has announced a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) for alleged violations of federal securities laws. The lawsuit claims that Freeport-McMoRan made false or misleading statements regarding safety at its Grasberg Block Cave mine in Indonesia between February 15, 2022, and September 24, 2025. Investors who suffered losses have until January 12, 2026, to request to be appointed as lead plaintiff.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | UBS | $60 | $55 | +9% |
| 2025-12-05 | JP Morgan | $58 | $50 | +16% |
| 2025-11-19 | Morgan Stanley | $44 | $46 | -4% |
| 2025-11-19 | BMO Capital | $47 | $48 | -2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | UBS | main | Buy |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-11-19 | Morgan Stanley | main | Overweight |
| 2025-11-19 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.05M) |
| Sells | 3 ($1.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 4.2x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +4.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 4.21 signals overvaluation risk, limited margin of safety. Forward P/E 21.4x attractive for 45% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment negative (3 target cuts vs 2 raises). Insider selling cluster ($1.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $68.2B |
| Beta | 1.48 |
| 52W Range | $27.66 - $49.12 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.21 |
| Forward P/E | 21.4 |
| Current P/E | 31.1 |
| YoY Growth | 45.2% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from 1.9% to 5.9% (+4.0% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 90th percentile. MRS_5 at 3.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.52), confirming momentum. OFD pattern: -FTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.87% (CS: 91) | Strong |
| RSI_14 | 69.8 | Neutral |
| MACD Histogram | 0.52 | Bullish |
| vs SMA20 | 1.097x | Above |
| vs SMA50 | 1.130x | Above |
| vs SMA200 | 1.165x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $47.52
- **Stop Loss:** $44.42 (6.5% risk)
- **Target:** $52.17 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 387
- **Position Value:** $18,390.24
- **Portfolio %:** 18.39%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*